scPharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Summary

scPharmaceuticals (Nasdaq: SCPH), a pharmaceutical company specializing in optimizing infused therapies, announced that CEO John Tucker will present at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022, in New York. His presentation will be available for on-demand viewing starting September 12 at 7:00 am ET. Attendees can also schedule virtual one-on-one meetings with Tucker during the conference. The replay will be accessible in the Investor Relations section of scPharmaceuticals' website.

BURLINGTON, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, announced today that John Tucker, president & chief executive officer, is scheduled to present virtually at the H.C. Wainwright 24^th Annual Global Investment Conference, which is being held in a hybrid format, in-person and virtually, from September 12-14 in New York.

Mr. Tucker’s presentation will be available for on-demand viewing beginning at 7:00am ET on Monday, September 12. In addition, Mr. Tucker is available to host virtual one-on-one meetings with interested conference participants for the duration of the conference.

A replay of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com 

Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com 

FAQ

When is John Tucker presenting at the H.C. Wainwright Conference for scPharmaceuticals (SCPH)?

John Tucker will present virtually at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022.

How can I view John Tucker's presentation for scPharmaceuticals (SCPH)?

The presentation will be available for on-demand viewing starting at 7:00 am ET on September 12, 2022.

Will John Tucker have meetings during the H.C. Wainwright Conference for scPharmaceuticals (SCPH)?

Yes, John Tucker is available for virtual one-on-one meetings with conference participants for the duration of the event.

Where can I find the replay of John Tucker's presentation for scPharmaceuticals (SCPH)?

The replay will be accessible under 'News & Events' in the Investor Relations section of scPharmaceuticals' website.